Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
Not Applicable
Not yet recruiting
- Conditions
- Aortic Stenosis Treated With TAVIAortic Diseases
- First Posted Date
- 2024-11-15
- Last Posted Date
- 2025-02-17
- Lead Sponsor
- EnCompass Technologies, Inc.
- Target Recruit Count
- 500
- Registration Number
- NCT06689839
- Locations
- ๐บ๐ธ
St. Vincent Hospital, Indianapolis, Indiana, United States
๐บ๐ธHenry Ford Hospital, Detroit, Michigan, United States
๐บ๐ธSt. Lukes Hospital Of Kansas City, Kansas City, Missouri, United States
U.S. Multicenter Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
Not Applicable
Withdrawn
- Conditions
- Aortic Stenosis
- Interventions
- Device: Aortic Stenosis
- First Posted Date
- 2023-10-06
- Last Posted Date
- 2025-02-25
- Lead Sponsor
- EnCompass Technologies, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT06069661
- Locations
- ๐บ๐ธ
New York Presbyterian/Columbia University, New York, New York, United States
Multicenter Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
Not Applicable
Completed
- Conditions
- Aortic Stenosis
- Interventions
- Device: F2 Filter and Delivery System
- First Posted Date
- 2023-06-07
- Last Posted Date
- 2025-02-17
- Lead Sponsor
- EnCompass Technologies, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT05893082
- Locations
- ๐ฆ๐บ
North Shore Private, Sydney, New South Wales, Australia
Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
Early Phase 1
Recruiting
- Conditions
- Aortic Stenosis
- Interventions
- Device: F2 filter and delivery system
- First Posted Date
- 2023-05-19
- Last Posted Date
- 2025-02-25
- Lead Sponsor
- EnCompass Technologies, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT05866640
- Locations
- ๐ฌ๐ช
Healthycore, Tbilisi, Georgia
ยฉ Copyright 2025. All Rights Reserved by MedPath